Donald Trump, the former President of the United States, signed an executive order focused on expanding access to in vitro fertilization (IVF) from his Mar-a-Lago residence.

According to White House Press Secretary Karoline Leavitt, the order instructs the assistant to the president for domestic policy to develop a comprehensive list of policy recommendations aimed at protecting access to IVF and substantially lowering out-of-pocket expenses and health plan costs associated with these treatments.

The executive order mandates that these recommendations be submitted to Trump within 90 days.

This initiative follows heightened scrutiny of fertility treatment access in the aftermath of a ruling by the Alabama Supreme Court, which classified embryos as 'extrauterine children'.

This decision led to the cessation of IVF services at the state's largest fertility clinics, raising alarms among reproductive rights advocates and supporters of assisted reproductive technologies.

In broader context, the executive order emerges during a politically charged period marked by significant transitions within the federal government.

Other recent developments include mass layoffs affecting federal employees across various agencies, including the Internal Revenue Service and the Federal Aviation Administration.

Concerns have been raised by lawmakers regarding the potential impact of these layoffs on essential government operations and services.

In related news, discussions surrounding U.S. foreign policy continue as high-level talks between U.S. and Russian officials take place in Saudi Arabia, with ongoing implications for the war in Ukraine.

European leaders are also set to convene in France to discuss their responses to escalating tensions in the region.

As global attention focuses on these developments, Trump's executive order on IVF access represents a notable shift in health policy within the current political landscape, with implications for many Americans seeking fertility treatments.